Somaira Nowsheen, MD
Dermatology · Waukee, IANPI 1003445610
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Boehringer Ingelheim at 48.8% of the total. Reporting peaked in 2022 at $8,212 and has fallen 75.1% since, to $2,046 in 2025. Among dermatology clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $90.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$7K
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$781
- Johnson & Johnson$676
- UCB, Inc.$564
- Incyte Corporation$521
- plus $3K from 20 others
What the payments were for
- Consulting fees$5,67037%
- Travel & lodging$2,14514%
- Food & beverage$7,22747%
- Education$2482%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 13 | $7,457 |
| AbbVie(2 entities) | 34 | $2,023 |
| E.r. Squibb & Sons, L.L.C. | 10 | $781 |
| Johnson & Johnson | 21 | $676 |
| UCB, Inc. | 16 | $564 |
| Incyte Corporation | 5 | $521 |
| Sanofi | 7 | $471 |
| Dermavant Sciences, Inc. | 4 | $441 |
| Sun Pharmaceutical Industries Inc. | 8 | $348 |
| Regeneron Healthcare Solutions, Inc. | 9 | $296 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $284 |
| Amgen | 5 | $209 |
| Novartis | 5 | $195 |
| Janssen Scientific Affairs, LLC | 2 | $166 |
| Galderma Laboratories, L.p. | 8 | $164 |
| Lilly USA, LLC | 6 | $142 |
| LEO Pharma Inc. | 1 | $122 |
| Regeneron | 1 | $109 |
| Pfizer | 1 | $81 |
| Arcutis Biotherapeutics, Inc. | 1 | $63 |
| Organon | 3 | $40 |
| Botanix SB Inc | 2 | $35 |
| EPI Health, LLC | 1 | $35 |
| Organogenesis Inc. | 1 | $26 |
| LNHC, Inc | 1 | $21 |
| Strata Skin Sciences, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,290 in reported general payments places this provider in the 90th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 116 | $1,679 |
| Triamcinolone Acetonide | 47 | $966 |
| Clobetasol Propionate | 14 | $816 |
| Doxycycline Hyclate | 29 | $495 |
| Clindamycin Phosphate | 20 | $461 |
| Mupirocin | 15 | $118 |
| Hydrocortisone | 11 | $76 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Waukee
- Adam MillerWaukee$2K
- Roger CeilleyWest Des Moines$82K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Ravindrakumar GangadhariahDavenport$20K
- Laura MyersAnkeny$7K
- Katrina SmithAnkeny$7K
- Kirsten DickinsonClive$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.